Home › Funds › Hood River Capital Management LLC › PTCT
Hood River Capital Management LLC position in PTCT
PTC THERAPEUTICS INC · Health Care
Hood River Capital Management LLC reported holding 1,756,325 shares of PTCT (PTC THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$113.8M, representing 0.96% of its reported portfolio and ranking #29 among its reported holdings. Hood River Capital Management LLC has disclosed PTCT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Hood River Capital Management LLC's PTCT position evolved
Hood River Capital Management LLC first disclosed a stake in PTCT in Q1 2025 at 84,372 shares (US$4.3M). The position peaked in Q2 2026 at 1,738,613 shares, worth US$141.8M. Across 7 filings, Hood River Capital Management LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,756,325 shares valued at US$113.8M — an increase of 17,712 shares quarter over quarter.. Notable position changes include a 654% increase in Q2 2025 (shares rose 26% over the following quarter), a 56% increase in Q3 2025 (shares rose 24% over the following quarter), a 66% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 84.37K | $4.30M | New |
| Q2 2025 | 636.50K | $31.09M | Add |
| Q3 2025 | 995.78K | $61.11M | Add |
| Q4 2025 | 1.00M | $76.19M | Add |
| Q1 2026 | 1.66M | $113.41M | Add |
| Q2 2026 | 1.74M | $141.82M | Add |
| Q3 2026 | 1.76M | $113.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in PTCT — the largest reported positions include TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M), TANG CAPITAL MANAGEMENT LLC (US$122.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- TORONTO DOMINION BANK 2.17M sh · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.70M sh · $174.86M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $122.36M · Q2 2026
- RTW INVESTMENTS, LP 1.62M sh · $104.67M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.30M sh · $84.05M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.24M sh · $80.11M · Q3 2026
- Palo Alto Investors LP 918.85K sh · $74.95M · Q2 2026
- Parkman Healthcare Partners LLC 700.39K sh · $45.37M · Q3 2026
More on Hood River Capital Management LLC
FAQ
How long has Hood River Capital Management LLC held PTCT?
Hood River Capital Management LLC has disclosed PTCT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Hood River Capital Management LLC's current position in PTCT?
As of Q3 2026, Hood River Capital Management LLC holds 1.76M shares of PTCT (PTC THERAPEUTICS INC), valued at $113.77M, representing 0.96% of its reported portfolio and ranking #29.
Has Hood River Capital Management LLC been buying or selling PTCT?
In the latest 13F filing (Q3 2026), Hood River Capital Management LLC increased its position in PTCT. The position peaked in Q2 2026 at 1.74M shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, TANG CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.